Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04278313 · ClinicalTrials.gov registry record · NA

Ovarian Function Following Intraovarian Injection of PRP

A NA study of Diminished Ovarian Reserve and Diminished Ovarian Reserve Due to Advanced Maternal Age, sponsored by Center for Human Reproduction.

Active
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT04278313 is a NA study of Diminished Ovarian Reserve and Diminished Ovarian Reserve Due to Advanced Maternal Age that is active but no longer recruiting, run by Center for Human Reproduction. The registered enrollment target is 90 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04278313, a NA study of Diminished Ovarian Reserve and Diminished Ovarian Reserve Due to Advanced Maternal Age, is active but no longer recruiting, sponsored by Center for Human Reproduction.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

Consenting women with evidence of poor ovarian reserve will be randomly assigned to treatment with either Platelet Rich Plasma (PRP) or Platelet Poor Plasma (PPP).

Interventions

  • PROCEDURE PRP - Platelet Rich Plasma
  • PROCEDURE PPP - Platelet Poor Plasma

Study Locations (1)

New York

  • Center for Human Reproduction - New York

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2020-02-24
Est. Completion 2026-12-31
Phase NA

Sponsor

Center for Human Reproduction

8 total trials

What the Registry Record Tells You About NCT04278313

The ClinicalTrials.gov registry entry for NCT04278313 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Center for Human Reproduction, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Diminished Ovarian Reserve appearing as the primary indexed condition, and to 2 interventions - of which PRP - Platelet Rich Plasma is the first listed.

NCT04278313 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04278313 about?

NCT04278313 is a clinical study titled "Ovarian Function Following Intraovarian Injection of PRP". Consenting women with evidence of poor ovarian reserve will be randomly assigned to treatment with either Platelet Rich Plasma (PRP) or Platelet Poor Plasma (PPP).

What is the current status of trial NCT04278313?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2020-02-24. Estimated completion is 2026-12-31.

What conditions does trial NCT04278313 study?

This clinical trial studies the following conditions: Diminished Ovarian Reserve, Diminished Ovarian Reserve Due to Advanced Maternal Age.

What interventions are being tested in trial NCT04278313?

The interventions under investigation include: PRP - Platelet Rich Plasma (PROCEDURE), PPP - Platelet Poor Plasma (PROCEDURE).

Who is sponsoring clinical trial NCT04278313?

This trial is sponsored by Center for Human Reproduction, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04278313 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diminished Ovarian Reserve

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.